Researchers in the Molecular Vision Research Cluster (MVRC) at the University of Auckland are calling for eyecare professionals to refer a specific cohort of patients for a study they hope will result in new treatments for cataract and presbyopia.
The team behind the Vision Bus Aotearoa (VBA) is seeking new funding to support continued mobile eyecare service delivery to underserved schools, primarily in the South Auckland region. Funded entir
Ophthalmic nurse Kathryn Millichamp shares her highlights from RANZCO NZ 2025
Pharmac has swapped funding from nepafenac (Ilvero) to diclofenac sodium (Devatis) eye drops. Ilevro nepafenac drops were a temporary replacement for Voltaren Ophtha, for which there were supply gaps
Bringing together brilliant minds from NZ and further afield, RANZCO NZ Branch Meeting offered an abundance of new insights in ophthalmology.
Dr Peter Hadden fleshes out risks and benefits of new, promising treatments for melanomas and naevi
Chalkeyes calls for collective effort, for optometrists to stand together to gain real advocacy and reform
The desire to care for vision and enable patients to see to the best of their ability is at the heart of why most of us are working in the optical industry. Good vision isn’t just about clarity, it’s about enhancing quality of life – whether it's reading a book, driving safely or simply enjoying a b
Excellent clinical skills are not all your practice needs to stand out; connection and communication is equally important
At first glance, this appeared to be a 74-year-old man struggling with the aftermath of a transient ischaemic attack (TIA). The referral letter stated: Ocular diagnosis Right homonymous hemianopi
With more than 20 years’ experience in the optics industry, Stu Allan, licenced real estate agent and managing director of Optics NZ, said he always gets interest in buying practices from independent
The challenges of recruiting staff and attracting buyers to regional New Zealand